Panida Navasumrit Selected Research

aspergillusidone A

1/2017

Depsidones inhibit aromatase activity and tumor cell proliferation in a co-culture of human primary breast adipose fibroblasts and T47D breast tumor cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Panida Navasumrit Research Topics

Disease

18	Neoplasms (Cancer) 12/2022 - 05/2005
4	Inflammation (Inflammations) 01/2023 - 11/2007
4	Breast Neoplasms (Breast Cancer) 01/2017 - 11/2013
3	Cholangiocarcinoma 12/2022 - 08/2018
3	Chronic Disease (Chronic Diseases) 07/2022 - 11/2007
2	Liver Neoplasms (Liver Cancer) 01/2022 - 01/2015
2	Vitamin B 6 Deficiency (Pyridoxine Deficiency) 01/2021 - 09/2009
2	Carcinogenesis 01/2017 - 05/2012
2	Chromosome Aberrations (Chromosome Abnormalities) 09/2010 - 01/2007
1	Metabolic Diseases (Metabolic Disease) 01/2023
1	Liver Diseases (Liver Disease) 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 06/2017
1	Myeloid Leukemia (Leukemia, Myelocytic) 06/2017
1	Triple Negative Breast Neoplasms 11/2013
1	Congenital Abnormalities (Deformity) 05/2012
1	Weight Gain 09/2009
1	Lymphoma (Lymphomas) 05/2005
1	Leukemia 05/2005

Drug/Important Bio-Agent (IBA)

8	ArsenicIBA 01/2023 - 11/2007
5	Benzene (Benzole)IBA 01/2021 - 05/2005
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 09/2016
3	Biomarkers (Surrogate Marker)IBA 01/2017 - 01/2007
2	Messenger RNA (mRNA)IBA 01/2023 - 01/2017
2	Pyridoxine (Pyridoxin)FDA LinkGeneric 01/2021 - 09/2009
2	Cytochrome P-450 CYP2E1 (CYP2E1)IBA 01/2021 - 09/2009
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 09/2010
2	Argininosuccinate Synthase (Argininosuccinate Synthetase)IBA 08/2018 - 06/2017
2	ADI PEG20IBA 08/2018 - 06/2017
2	Aromatase (CYP19)IBA 01/2017 - 10/2014
2	1,3-butadiene (divinyl)IBA 01/2017 - 09/2010
2	Estrogen ReceptorsIBA 09/2016 - 10/2014
2	Androgen Receptors (Androgen Receptor)IBA 09/2016 - 11/2013
2	Testosterone (Sustanon)FDA Link 10/2014 - 11/2013
1	CytokinesIBA 01/2023
1	arseniteIBA 01/2023
1	AdipokinesIBA 01/2023
1	Collagen Type I (Type I Collagen)IBA 12/2022
1	CollagenIBA 12/2022
1	IntegrinsIBA 12/2022
1	Methylene Chloride (Dichloromethane)IBA 09/2021
1	Temozolomide (Temodar)FDA LinkGeneric 01/2020
1	MethyltransferasesIBA 01/2020
1	Arginine (L-Arginine)FDA Link 06/2017
1	Fluorouracil (Carac)FDA LinkGeneric 06/2017
1	Apoptosis Regulatory ProteinsIBA 06/2017
1	X-Linked Inhibitor of Apoptosis ProteinIBA 06/2017
1	EnzymesIBA 06/2017
1	8-nitroguanineIBA 01/2017
1	aspergillusidone AIBA 01/2017
1	unguinolIBA 01/2017
1	Progesterone Receptors (Progesterone Receptor)IBA 09/2016
1	human ERBB2 proteinIBA 09/2016
1	Aflatoxin B1 (Aflatoxin B)IBA 01/2015
1	sulforaphaneIBA 01/2015
1	Aromatase InhibitorsIBA 10/2014
1	MelatoninIBA 10/2014
1	Estrogens (Estrogen)FDA Link 10/2014
1	Estradiol (Delestrogen)FDA LinkGeneric 10/2014
1	ResveratrolIBA 10/2014
1	Letrozole (Femara)FDA LinkGeneric 10/2014
1	AndrogensIBA 11/2013
1	8-Hydroxy-2'-DeoxyguanosineIBA 09/2010
1	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 09/2009
1	5'- O- (6- O- malonylglucopyranosyl)pyridoxineIBA 09/2009
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 09/2009
1	Hemoglobins (Hemoglobin)IBA 09/2009
1	CarcinogensIBA 05/2008
1	NF-kappa B (NF-kB)IBA 11/2007
1	MetalsIBA 11/2007
1	Environmental Pollutants (Pollutants, Environmental)IBA 04/2007

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2020
1	Therapeutics 01/2020